Attached files
| file | filename |
|---|---|
| 10-K - 10-K - BIOCEPT INC | bioc-10k_20191231.htm |
| EX-32.2 - EX-32.2 - BIOCEPT INC | bioc-ex322_10.htm |
| EX-32.1 - EX-32.1 - BIOCEPT INC | bioc-ex321_6.htm |
| EX-31.2 - EX-31.2 - BIOCEPT INC | bioc-ex312_9.htm |
| EX-31.1 - EX-31.1 - BIOCEPT INC | bioc-ex311_7.htm |
| EX-4.3 - EX-4.3 - BIOCEPT INC | bioc-ex43_152.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As independent registered public accountants, we hereby consent to the incorporation by reference in Registration Statement Nos. 333-194930, 333-202656, 333-206347, 333-212960, 333-218018, 333-227267, 333-227900 and 333-233285 on Forms S-8, Registration Statement Nos. 333-224946 and 333-220048 on Forms S-3, and Registration Statement Nos. 333-234459, 333-230797, 333-228566, 333-227908 on Forms S-1 of our report dated March 27, 2020, relating to the financial statements of Biocept, Inc. (“Company”) (which includes explanatory paragraphs related to the change in the method of accounting for leases, and the uncertainty of the Company’s ability to continue as a going concern), included in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 27, 2020